CSIMarket
 


Galmed Pharmaceuticals Ltd   (GLMD)
Other Ticker:  
 

Cumulative Galmed Pharmaceuticals Ltd 's Leverage Ratio for Trailing Twelve Months Period

GLMD's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

GLMD Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity Growth -55.99 % -55.99 % -55.99 % -55.99 % -30.93 %
Y / Y Total Liabilities Growth -47.37 % -47.37 % -47.37 % -47.37 % -26.62 %
Leverage Ratio for Trailing Twelve Months Period 0.23 0.21 0.2 0.2 0.19
Total Ranking # 668 # 629 # 639 # 640 # 619
Seq. Equity Growth 0 % 0 % 0 % -55.99 % 0 %
Seq. Total Liabilities Growth 0 % 0 % 0 % -47.37 % 0 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Despite debt repayement of 0% in IV. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.23, above Galmed Pharmaceuticals Ltd 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 198 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Galmed Pharmaceuticals Ltd . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are GLMD's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 199
Sector # 331
S&P 500 # 642


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.24 0.15 0.03
(Dec 31 2017)   (Dec 31 2018)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Tenax Therapeutics Inc   0.63 
Qualigen Therapeutics Inc   0.62 
Elite Pharmaceuticals Inc   0.61 
Nature s Sunshine Products inc   0.61 
Trevena inc   0.61 
Gri Bio Inc   0.60 
Avenue Therapeutics Inc   0.60 
Entasis Therapeutics Holdings Inc   0.60 
Organogenesis Holdings Inc   0.60 
Eagle Pharmaceuticals inc   0.59 
Macrogenics Inc   0.59 
Otonomy Inc   0.58 
Tango Therapeutics Inc   0.58 
Equillium Inc   0.57 
Atreca inc   0.56 
Verastem inc   0.56 
Hutchmed china Limited  0.56 
Inventiva S a   0.56 
Casi Pharmaceuticals inc   0.56 
Frequency Therapeutics Inc   0.54 
Cerevel Therapeutics Holdings Inc   0.54 
Integrated Biopharma Inc  0.52 
Scpharmaceuticals Inc   0.52 
Iterum Therapeutics Plc  0.52 
Scisparc Ltd   0.52 
Neurobo Pharmaceuticals Inc   0.52 
Igm Biosciences Inc   0.51 
Anaptysbio Inc   0.51 
Timber Pharmaceuticals Inc   0.50 
180 Life Sciences Corp  0.50 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com